TRANSCRIPT TO FOLLOW
The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.
Responsibility for the management Alliance Trust will be moving to Willis Towers Watson, where...
Morningstar senior fund analyst David Holder explains the recent upgrade of Fidelity Asian Val...
Which investment trusts have delivered top returns for their shareholders this year? Commoditi...
Developed market equities prove popular with closed-end fund investors - with infrastructure a...
Even the best fund managers struggle with market headwinds. We reveal three funds that are rat...
Mining companies are operating in a challenging environment but could now be the time to top up o...
THE WEEK: Morningstar columnist Rodney Hobson provides two pieces of advice to George Osborne, an...
Businesses that have competitive advantages within their industry are good candidates for dividen...
Morningstar reveals the top 10 best performers over the last five years
Morningstar OBSR reveals the top funds for investors seeking exposure to European equities
Activist defeated again as more shareholders vote on trust takeovers.
Guinness maker is well positioned to capitalize on long-term secular drivers.
Palantir shows exemplary execution and continued penetration of the US commercial market.
Investors will be closely watching GLP-1 market share, manufacturing, and drug pipeline.
Smiths Group and Intermediate Capital Group are among the month’s high-yielding winners.
Security Name | Price | Change (%) | Morningstar Rating |
---|---|---|---|
Templeton Emerging Mkts Invmt Tr TEMIT | 169.60 GBX | 0.24 |
Emma Wall is former Senior International Editor for Morningstar